Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,235,145
-
Total 13F shares
-
22,191,421
-
Share change
-
+2,594,652
-
Total reported value
-
$862,345,865
-
Price per share
-
$38.86
-
Number of holders
-
94
-
Value change
-
+$92,686,286
-
Number of buys
-
53
-
Number of sells
-
29
Institutional Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q1 2021
As of 31 Mar 2021,
Kymera Therapeutics, Inc. - Common Stock (KYMR) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,191,421 shares.
The largest 10 holders included
BVF INC/IL, Redmile Group, LLC, FMR LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Deer IX & Co. Ltd., BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
94
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.